A novel compound heterozygous fshr variant associated with primary amenorrhea: The first case report in Vietnam

Dao Thi Trang, Nguyen Thi Minh Khai, Nguyen Thi Nga, Nguyen Thi Minh Ngoc, Nguyen Thi Trang, Hoang Thu Lan

Nội dung chính của bài viết

Tóm tắt

Primary amenorrhea is a rare condition with heterogeneous causes, including anatomic and sexual development problems, ovarian insufficiency, hypothalamus or pituitary illnesses, and other endocrine gland disorders. Genetic etiology may involve chromosomal abnormalities or gene mutations. Variants in the follicle-stimulating hormone receptor (FSHR) gene are extremely rare, with only a few cases reported worldwide. We describe a 32-year-old Vietnamese female with primary amenorrhea and repeated in vitro fertilization failure due to absent ovarian response. She exhibited a small uterus on ultrasound, and hormonal testing results of ovarian insufficiency status and a normal 46,XX karyotype. Clinical exome sequencing revealed an in trans compound heterozygous FSHR variant: c.656_659del and c.263C>T, which were classified as likely pathogenic and variant of uncertain significance with high possibility of pathogenicity, accordingly. Despite gonadotropin stimulation at a high dose, the woman failed to produce mature oocytes. This study reports the first Vietnamese case with primary amenorrhea that is related to novel FSHR variants. The findings expand the FSHR mutation spectrum and underscore the importance of genetic testing and counseling in unexplained ovarian insufficiency.

Chi tiết bài viết

Tài liệu tham khảo

1. Laven JSE. Primary Ovarian Insufficiency. Semin Reprod Med. 2016; 34(4): 230-234. doi:10.1055/s-0036-1585402.
2. Aittomäki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995; 82(6): 959-968. doi:10.1016/0092-8674(95)90275-9.
3. Desai SS, Roy BS, Mahale SD. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reproduction. 2013; 146(6): R235-R248. doi:10.1530/REP-13-0351.
4. Meduri G, Bachelot A, Cocca MP, et al. Molecular pathology of the FSH receptor: new insights into FSH physiology. Mol Cell Endocrinol. 2008; 282(1-2): 130-142. doi:10.1016/j.mce.2007.11.027.
5. Yoo S, Yoon JY, Keum C, Cheon CK. The first case of novel variants of the FSHR mutation causing primary amenorrhea in 2 siblings in Korea. Ann Pediatr Endocrinol Metab. 2023; 28(1): 54-60. doi:10.6065/apem.2142116.058.
6. Ke H, Tang S, Guo T, et al. Landscape of pathogenic mutations in premature ovarian insufficiency. Nat Med. 2023; 29(2): 483-492. doi:10.1038/s41591-022-02194-3.
7. Lee JY, Kim YR, Ko EJ, et al. Association of Polymorphisms in FSHR, ESR1, and BMP15 with Primary Ovarian Insufficiency and Meta-Analysis. Diagnostics. 2024; 14(17): 1889. doi:10.3390/diagnostics14171889.
8. Khor S, Lyu Q, Kuang Y, Lu X. Novel FSHR variants causing female resistant ovary syndrome. Mol Genet Genomic Med. 2020; 8(2): e1082. doi:10.1002/mgg3.1082.
9. Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Current evaluation of amenorrhea: a committee opinion. Fertil Steril. 2024; 122(1): 52-61. doi:10.1016/j.fertnstert.2024.02.001.
10. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. 2015; 17(5): 405-424. doi:10.1038/gim.2015.30.
11. European Society of Human Reproduction and Embryology (ESHRE) Guideline Group on POI. (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction, 31(5), 926-937. https://doi.org/10.1093/humrep/dew027.
12. Nelson, L. M. (2009). Clinical practice. Primary ovarian insufficiency. New England Journal of Medicine, 360(6), 606-614. https://doi.org/10.1056/NEJMcp0808697
13. Fan QR, Hendrickson WA. Structure of human follicle-stimulating hormone in complex with its receptor. Nature. 2005;433(7023):269-277. doi:10.1038/nature03206.